Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracystic methotrexate injection for simple ovarian cysts in postmenopausal women
PACTR201810634381311Phase 0Recruiting
- Sponsor
- Tanta University
- Start
- Jun 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 0, open-label trial of methotrexate in ovarian cyst (2 arms), sponsored by Tanta University. Primary endpoint: Recurrence of the cyst. Started Jun 2018; status: recruiting.
02
Drugs
methotrexate
03
Conditions
ovarian cyst
Beyond the preview
Go deeper on PACTR201810634381311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201810634381311.